Kinexum Services Innovation team recently assisted a global pharmaceutical company with their evaluation of complimentary digital technology to assist their commercial team as they moved “beyond the pill”.

The Kinexum Innovation team was comprised of our Innovation Practice Lead, Elizabeth Whalley-Buono,  a clinical and outcomes specialist, a market and medical device specialist, and a human factors specialist. After learning about the challenge the innovation team formulated and detailed a Digital Technology Evaluation Process (D-TEP) for the client.  The D-TEP process was designed as a funnel taking Digital medicines and other product candidates through a three staged process. In the process candidates would be reviewed, assessed, and researched to determine if the product candidate should be moved to the commercial side for thier review or abandoned.

In the end, the client was very happy with the outcomes and planned to review with senior management.


To learn more contact Steve Casey or Elizabeth Whalley-Buono